
Christopher P. Jones
Examiner (ID: 5555, Phone: (571)270-7383 , Office: P/1776 )
| Most Active Art Unit | 1776 |
| Art Unit(s) | 1776, 1797 |
| Total Applications | 1840 |
| Issued Applications | 1378 |
| Pending Applications | 121 |
| Abandoned Applications | 373 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14929895
[patent_doc_number] => 20190300585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => DENDRITIC-CELL-TARGETED PEPTIDE, FUSION PEPTIDE UTILIZING SAID PEPTIDE, AND VACCINE UTILIZING SAID FUSION PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/335625
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335625 | Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide | Sep 20, 2017 | Issued |
Array
(
[id] => 12624504
[patent_doc_number] => 20180099998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/699482
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699482 | None | Sep 7, 2017 | Issued |
Array
(
[id] => 17741449
[patent_doc_number] => 11389494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Composition for suppressing or improving eye fatigue
[patent_app_type] => utility
[patent_app_number] => 16/331849
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14598
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331849 | Composition for suppressing or improving eye fatigue | Sep 7, 2017 | Issued |
Array
(
[id] => 15239687
[patent_doc_number] => 20190374629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/331863
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331863 | THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS | Sep 6, 2017 | Pending |
Array
(
[id] => 19519851
[patent_doc_number] => 12121549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => Application of
[patent_app_type] => utility
[patent_app_number] => 16/642741
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8823
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642741 | Application of | Aug 28, 2017 | Issued |
Array
(
[id] => 17185227
[patent_doc_number] => 20210332112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE
[patent_app_type] => utility
[patent_app_number] => 16/325710
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325710 | STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE | Aug 14, 2017 | Abandoned |
Array
(
[id] => 14375243
[patent_doc_number] => 20190161534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 16/321528
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321528 | ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE | Aug 10, 2017 | Abandoned |
Array
(
[id] => 13699803
[patent_doc_number] => 20170360856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/673270
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673270 | Compositions comprising bacterial strains | Aug 8, 2017 | Issued |
Array
(
[id] => 13699803
[patent_doc_number] => 20170360856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/673270
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673270 | Compositions comprising bacterial strains | Aug 8, 2017 | Issued |
Array
(
[id] => 13699803
[patent_doc_number] => 20170360856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/673270
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673270 | Compositions comprising bacterial strains | Aug 8, 2017 | Issued |
Array
(
[id] => 13699803
[patent_doc_number] => 20170360856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/673270
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673270 | Compositions comprising bacterial strains | Aug 8, 2017 | Issued |
Array
(
[id] => 16862802
[patent_doc_number] => 11021534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Mycobacterial antigen composition
[patent_app_type] => utility
[patent_app_number] => 15/672085
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 28697
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672085 | Mycobacterial antigen composition | Aug 7, 2017 | Issued |
Array
(
[id] => 17392501
[patent_doc_number] => 11241489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition
[patent_app_type] => utility
[patent_app_number] => 16/322726
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 16115
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322726 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Aug 3, 2017 | Issued |
Array
(
[id] => 14980619
[patent_doc_number] => 10444217
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-10-15
[patent_title] => Rapid analysis for cyanobacterial toxins
[patent_app_type] => utility
[patent_app_number] => 15/667822
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11941
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667822 | Rapid analysis for cyanobacterial toxins | Aug 2, 2017 | Issued |
Array
(
[id] => 12049878
[patent_doc_number] => 20170326223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)'
[patent_app_type] => utility
[patent_app_number] => 15/660455
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25893
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660455
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660455 | Surface exposed | Jul 25, 2017 | Issued |
Array
(
[id] => 14715555
[patent_doc_number] => 20190248841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => Immunogenic Composition
[patent_app_type] => utility
[patent_app_number] => 16/308972
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308972 | Immunogenic Composition | Jun 14, 2017 | Abandoned |
Array
(
[id] => 14621467
[patent_doc_number] => 20190224101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => HUMAN ANTIBODY SPECIFICALLY BINDING TO ACNE BACTERIA USING PHAGE DISPLAY TECHNIQUE, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/309582
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309582 | Human antibody specifically binding to acne bacteria using phage display technique, and use thereof | Jun 12, 2017 | Issued |
Array
(
[id] => 16360987
[patent_doc_number] => 20200317738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/303483
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303483 | METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS | May 25, 2017 | Abandoned |
Array
(
[id] => 15898421
[patent_doc_number] => 20200148729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections
[patent_app_type] => utility
[patent_app_number] => 16/098911
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098911 | Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections | May 18, 2017 | Abandoned |
Array
(
[id] => 15145115
[patent_doc_number] => 20190351035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/311597
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311597 | VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION | May 1, 2017 | Abandoned |